1. ScholarBank@NUS

Lingzhi Wang

rp05443

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
Main Affiliation
 
Faculty
 
Email
csiwl@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Subject:  Gemcitabine

Results 1-6 of 6 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
1Apr-2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Goh, B.C.; Tan, E.H.; Lam, K.C.; Soo, R. ; Leong, S.S.; Wang, L.Z. ; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.
2Jul-2006A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancerSoo, R.A. ; Wang, L.Z. ; Tham, L.S.; Yong, W.P. ; Boyer, M.; Lim, H.L.; Lee, H.S.; Millward, M.; Liang, S.; Beale, P.; Lee, S.C. ; Goh, B.C.
3Oct-2003An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatographyWang, L.-Z. ; Goh, B.-C.; Lee, H.-S. ; Noordhuis, P.; Peters, G.J.
4Dec-2008Does saturable formation of gemcitabine triphosphate occur in patients?Tham, L.-S.; Wang, L.-Z. ; Soo, R.A. ; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.; Holford, N.H.G.
51-Aug-2003Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group studySoo, R.A. ; Lim, H.L.; Wang, L.Z. ; Lee, H.S.; Millward, M.J.; Tok, L.T.; Lee, S.C. ; Lehnert, M.; Goh, B.C.
62009Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effectWang, L.-Z. ; Yong, W.-P. ; Soo, R.-A. ; Lee, S.-C. ; Soong, R. ; Lee, H.-S.; Goh, B.-C.